Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1961 1
1968 2
1969 3
1970 4
1971 5
1972 4
1973 2
1974 2
1975 2
1976 1
1977 1
1979 2
1980 1
1982 1
1984 1
1985 2
1986 2
1987 1
1988 2
1989 5
1990 4
1991 7
1992 30
1993 44
1994 54
1995 99
1996 142
1997 191
1998 236
1999 319
2000 402
2001 493
2002 511
2003 590
2004 645
2005 859
2006 1060
2007 1180
2008 1136
2009 1175
2010 1254
2011 1454
2012 1467
2013 1477
2014 1414
2015 1427
2016 1281
2017 1277
2018 1204
2019 630
2020 27
Text availability
Article attribute
Article type
Publication date

Search Results

19,662 results
Results by year
Filters applied: . Clear all
Page 1
An Update on MDMX and Dual MDM2/X Inhibitors.
Espadinha M, Barcherini V, Lopes EA, Santos MMM. Espadinha M, et al. Curr Top Med Chem. 2018;18(8):647-660. doi: 10.2174/1568026618666180604080119. Curr Top Med Chem. 2018. PMID: 29866007 Review.
HMGB1 as biomarker and drug target.
Venereau E, De Leo F, Mezzapelle R, Careccia G, Musco G, Bianchi ME. Venereau E, et al. Pharmacol Res. 2016 Sep;111:534-544. doi: 10.1016/j.phrs.2016.06.031. Epub 2016 Jul 1. Pharmacol Res. 2016. PMID: 27378565 Review.
Targeting the replication stress response in cancer.
Forment JV, O'Connor MJ. Forment JV, et al. Pharmacol Ther. 2018 Aug;188:155-167. doi: 10.1016/j.pharmthera.2018.03.005. Epub 2018 Mar 24. Pharmacol Ther. 2018. PMID: 29580942 Review.
Peptide-based inhibitors of protein-protein interactions.
Wójcik P, Berlicki Ł. Wójcik P, et al. Bioorg Med Chem Lett. 2016 Feb 1;26(3):707-713. doi: 10.1016/j.bmcl.2015.12.084. Epub 2015 Dec 24. Bioorg Med Chem Lett. 2016. PMID: 26764190 Review.
A therapeutic patent overview of MDM2/X-targeted therapies (2014-2018).
Skalniak L, Surmiak E, Holak TA. Skalniak L, et al. Expert Opin Ther Pat. 2019 Mar;29(3):151-170. doi: 10.1080/13543776.2019.1582645. Epub 2019 Mar 1. Expert Opin Ther Pat. 2019. PMID: 30822185 Review.
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.
Jin X, Kim LJY, Wu Q, Wallace LC, Prager BC, Sanvoranart T, Gimple RC, Wang X, Mack SC, Miller TE, Huang P, Valentim CL, Zhou QG, Barnholtz-Sloan JS, Bao S, Sloan AE, Rich JN. Jin X, et al. Nat Med. 2017 Nov;23(11):1352-1361. doi: 10.1038/nm.4415. Epub 2017 Oct 9. Nat Med. 2017. PMID: 29035367 Free PMC article.
19,662 results
Jump to page
Feedback